Carien L. Creutzberg
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 191 publications
Assessing Foundation Models for Computational Pathology in Endometrial Cancer.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 05, 2026
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 21, 2026
Response to the letter to the editor by Pontoriero et al. regarding the article "Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international randomised phase 3 trial by Van den Heerik et al."
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 11, 2026
Investigators' response.
Journal: Clinical and translational radiation oncology
Published: April 08, 2026
Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 16, 2025
From evidence to practice: Real-world implementation of ESGO 2023 guidelines for adjuvant radiotherapy in vulvar cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 08, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial.
Journal: Obstetrical & gynecological survey
Published: October 30, 2025
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 21, 2025
Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 21, 2025
Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy.
Journal: Clinical and translational radiation oncology
Published: August 21, 2025
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial.
Journal: The Lancet. Oncology
Published: June 11, 2025
Clinicopathological and Molecular Characterization of High Grade Endometrial Carcinomas of No Specific Molecular Profile (NSMP) Stratified by ER Status.
Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: May 28, 2025
Last Updated: 09/26/2026